Evaluation of probiotics effectiveness in hospitalized pneumonia children by electronic medical records

SUN Huajun; GU Zhirui; CHE Datian; GAO Chunhui; YU Guangjun

doi:10.3969/j.issn.1006-0111.2014.06.013

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Objective To describe the profile of probiotics utilization in hospitalized pneumonia children and evaluate the effectiveness of probiotics in the treatment of pneumonia in hospitalized children combined with antibiotics. Methods Descriptive data analysis was obtained from the medical records in one children's hospital in one year period. The clinical data including patient characteristics, drug prescribed time, drug use duration, and length of stay was reviewed. Ridit analysis was used to compare the data. Results Data of 2 974 children hospitalized for pneumonia was accessed. Antibiotics were prescribed to 99.1% (n=2 948) of patients, probiotics were prescribed to 42.1% (n=1 252) of patients, and both antibiotics and probiotics were prescribed to 41.9%(n=1 246). The median of the time to start administration of probiotics was the second day of hospitalization and the mode was the first day of hospitalization. For those patients who were prescribed antibiotics combined with probiotics, the median of the duration of administration of antibiotics before accepting probiotics was 3 days and the mode was 1 day. After administrating probiotics, the median of the duration of accepting of antibiotics was 5 days, the mode was 4 days, and the median and the mode of the duration of administration of probiotics were 4 days. 21% (n=626) of all hospitalized patients were administrated anti-diarrheals. The most common age group of them were neonates and infants (82.3%, n=515). The patients with anti-diarrheal who was administrated antibiotics with or without probiotics were 585(47.0%), 34(2.0%), respectively (P<0.05). The median of duration of anti-diarrheals in those administrated antibiotics with probiotics was 4 days, the mode was 3 days and the interquartile range was 2-6 days. For those administrated antibiotics without probiotics, the median of duration of anti-diarrheals was 3 days, the mode was 1 day and the interquartile range was 1-6 days (P>0.05). The median of the length of stay in those administrated antibiotics with probiotics was 7 days, the mode was 6 days and the interquartile range was 6-9 days. For those administrated antibiotics without probiotics, the median and the mode of the length of stay were 7 days and the interquartile range was 6-9 days(P>0.05). Conclusion The time of starting to administrate probiotics was mainly within 2 days combined with antibiotics. The aim of prescribed probiotics was prevention of antibiotic-associated diarrhea. There was no significant difference in the duration of the following antibiotic therapy, the duration of anti-diarrhea therapy, the length of stay between those administrated antibiotics combination with or without probiotics.

Evaluation of probiotics effectiveness in hospitalized pneumonia children by electronic medical records

Shanghai Children's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200040, China

Received Date: 2014-07-01

Rev Recd Date: 2014-09-04

Key words:

Abstract: Objective To describe the profile of probiotics utilization in hospitalized pneumonia children and evaluate the effectiveness of probiotics in the treatment of pneumonia in hospitalized children combined with antibiotics. Methods Descriptive data analysis was obtained from the medical records in one children's hospital in one year period. The clinical data including patient characteristics, drug prescribed time, drug use duration, and length of stay was reviewed. Ridit analysis was used to compare the data. Results Data of 2 974 children hospitalized for pneumonia was accessed. Antibiotics were prescribed to 99.1% (n=2 948) of patients, probiotics were prescribed to 42.1% (n=1 252) of patients, and both antibiotics and probiotics were prescribed to 41.9%(n=1 246). The median of the time to start administration of probiotics was the second day of hospitalization and the mode was the first day of hospitalization. For those patients who were prescribed antibiotics combined with probiotics, the median of the duration of administration of antibiotics before accepting probiotics was 3 days and the mode was 1 day. After administrating probiotics, the median of the duration of accepting of antibiotics was 5 days, the mode was 4 days, and the median and the mode of the duration of administration of probiotics were 4 days. 21% (n=626) of all hospitalized patients were administrated anti-diarrheals. The most common age group of them were neonates and infants (82.3%, n=515). The patients with anti-diarrheal who was administrated antibiotics with or without probiotics were 585(47.0%), 34(2.0%), respectively (P<0.05). The median of duration of anti-diarrheals in those administrated antibiotics with probiotics was 4 days, the mode was 3 days and the interquartile range was 2-6 days. For those administrated antibiotics without probiotics, the median of duration of anti-diarrheals was 3 days, the mode was 1 day and the interquartile range was 1-6 days (P>0.05). The median of the length of stay in those administrated antibiotics with probiotics was 7 days, the mode was 6 days and the interquartile range was 6-9 days. For those administrated antibiotics without probiotics, the median and the mode of the length of stay were 7 days and the interquartile range was 6-9 days(P>0.05). Conclusion The time of starting to administrate probiotics was mainly within 2 days combined with antibiotics. The aim of prescribed probiotics was prevention of antibiotic-associated diarrhea. There was no significant difference in the duration of the following antibiotic therapy, the duration of anti-diarrhea therapy, the length of stay between those administrated antibiotics combination with or without probiotics.

HTML

Reference (9)

[1]	孙华君,顾之睿,高春辉,等. 大数据环境中肺炎住院患儿用药模式的描述性分析[J]. 药学服务与研究,2014,14(4):264-267.
[2]	朱宇丽. 双歧三联活菌治疗重症肺炎继发腹泻的疗效观察及影响因素分析[J]. 中国中西医结合消化杂志,2012,20(8):365-367.
[3]	吴斌,陈水利,张晓燕,等. 微生态制剂防治婴幼儿肺炎继发腹泻的卫生经济学评价[J]. 中国微生态学杂志,2012,24(10):901-903.
[4]	中华预防医学会微生态学分会儿科学组. 微生态制剂儿科应用专家共识(2010年)[J]. 中国实用儿科杂志,2011,26(1):20-23.
[5]	中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南(上,2013修订)[J]. 中华儿科杂志,2013,51(10):745-752.
[6]	中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南(下,2013修订)[J]. 中华儿科杂志,2013,51(11):856-862.
[7]	陈秀奇,王琳琳,单庆文,等. 微生态制剂预防儿童抗生素相关性腹泻的Meta分析[J]. 中国实用儿科杂志,2010,25(4):303-308.
[8]	Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America[EB/OL][2014-01-15]. http//www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/2011%2520CAP%2520in%2520Children.pdf.
[9]	National Collaborating Centre for Women's and Children's Health (UK). Diarrhoea and vomiting caused by gastroenteritis:diagnosis, assessment and management in children younger than 5 years[EB/OL][2014-01-15]. http://www.guideline.gov/content.aspx?id=14445.

Message Board

Evaluation of probiotics effectiveness in hospitalized pneumonia children by electronic medical records

doi: 10.3969/j.issn.1006-0111.2014.06.013

Abstract

References

Proportional views

通讯作者: 陈斌, [email protected]

Article Metrics

Related

Proportional views